Clinical Trials Logo

Dry Eye clinical trials

View clinical trials related to Dry Eye.

Filter by:

NCT ID: NCT05748951 Recruiting - Dry Eye Clinical Trials

Evaluating a Device for Blocking the Tear Duct

Start date: March 7, 2023
Phase: N/A
Study type: Interventional

Participants will receive a tear duct plug to see if their eye comfort improves.

NCT ID: NCT05741216 Completed - Dry Eye Clinical Trials

Evaluation of Comfort of Ocular Lubricants in Symptomatic Contact Lens Wearers

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the ocular comfort of 3 ocular lubricants and a comparator.

NCT ID: NCT05737108 Recruiting - Dry Eye Clinical Trials

Bilberry-containing Capsules for Dry Eye Mitigation

Start date: August 24, 2022
Phase: N/A
Study type: Interventional

This study investigates whether the oral intake of a bilberry capsule product may relieve dry eye symptoms. Participants will be aged between 20 - 65 years of age, with confirmed diagnosis of dry eye status. The participants will be assessed for several parameters and asked to take 4 bilberry capsules per day for 30 days. The parameters will include ocular surface health, tear volume, tear quality, intraocular pressure, and tear compositions. After the 30 days are completed, the participants will be assessed again for the same parameters.

NCT ID: NCT05720754 Not yet recruiting - Dry Eye Clinical Trials

Temperature on Evaporative Dry Eye

Start date: April 2, 2023
Phase: N/A
Study type: Interventional

Ocular surface temperature of a normal person is around 34.6 degree centigrade. After instilling the eye drop, depending on the temperature of the eye drop and the ocular surface, the ocular surface temperature will temporally increase or decrease sightly. Warm feeling will make blood vessels dilated and more blood will pass through to bring more blood flow out of our body to the heated area of the body and makes cells more permeable. Therefore, heating the ocular surface with heated eye mask after instilling artificial tears has the possibility to improve drug permeability on the ocular surface.

NCT ID: NCT05705518 Completed - Dry Eye Clinical Trials

Artificial Tears, Tear Lipids and Tear Film Dynamics

AlconAT
Start date: January 30, 2023
Phase: Phase 4
Study type: Interventional

Dry eye disease (DED) is pervasive with some reports estimating over 16 million adults diagnosed in the United States. Currently, artificial tears remain an integral part of managing dry eyes and are mainly used for symptomatic relief. Recent studies have shown there may be therapeutic benefits with regular use of lipid-based artificial tears to improve the structure of the tear film, which may improve tear film stability and provide relief of symptoms. In this study the investigators propose to compare effects on the tear lipid film and its dynamics between 3 lipid based artificial tears and a widely available non-lipid based artificial tear.

NCT ID: NCT05700422 Completed - Dry Eye Clinical Trials

Nasal Spray Study in Sjogren's Dry Eye Disease

Start date: May 1, 2023
Phase: Phase 4
Study type: Interventional

This study will investigate how well OC-01 (varenicline) nasal spray can treat the signs and symptoms of dry eye disease in those Sjogren's Syndrome. Patients at least 18 years old with moderate-to-severe Sjogren's dry eye disease may be eligible for this study. If you are eligible to participate in the study and you decide to join, there will be 3 study visits over approximately 1 month. You will also self-administer the nasal spray at home every day, 2 times a day during this month.

NCT ID: NCT05694026 Completed - Dry Eye Clinical Trials

Management of DE With IPL in Combination With DQS

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

Intense pulsed light (IPL) has been reported to improve signs and symptoms of dry eye (DE). Additionally, meibomian gland secretion of lipids has been observed to improve through the use of IPL. Diquafosol ophthalmic solution (DQS) stimulates P2Y2 receptors on the ocular surface, which enhances mucin secretion from goblet cells. Therefore, tear film stability and hydration of the ocular surface can be achieved independent from lacrimal glands function. The purpose of this prospective study was to evaluate and compare the effects of IPL (IPL group), DQS (DQS group) and IPL in combination with DQS (IPL+ group) in participants with persistent DE. Tear film lipid layer (TFLL), non-invasive breakup time (NITBUT), tear meniscus height (TMH), corneoconjunctival staining score (CS), meibum gland (MG) function, conjunctival hyperemia (RS score), ocular surface disease index (OSDI) will be assessed and compared at baseline, day-14, and day-28.

NCT ID: NCT05692739 Recruiting - Dry Eye Clinical Trials

Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye

Start date: October 5, 2022
Phase: Phase 4
Study type: Interventional

This is a parallel randomized controlled trial for the treatment of dry eye disease. The main objective is to investigate the efficacy and safety of the use of insulin eye drops in the control of moderate-severe dry eye disease. Topical insulin drops will be compared to the current gold standard treatment, cyclosporin and placebo (artificial tears).

NCT ID: NCT05661851 Completed - Dry Eye Clinical Trials

Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients

Start date: February 23, 2023
Phase: Phase 2
Study type: Interventional

This is a 30-Day, multi-site, single-masked, bilateral, active- controlled, 2-Arm parallel group study to evaluate the safety and efficacy of an Investigational product.

NCT ID: NCT05632887 Not yet recruiting - Dry Eye Clinical Trials

The Effect of Eyeliner on Tear Composition, Tear Secretion and Tear Film Stability.

Start date: February 15, 2023
Phase:
Study type: Observational

Eyeliner is one of the most common eye cosmetics. The main ingredients are titanium oxide, pigment, grease and preservative. The user will apply the eyeliner to the eyelid and eyelash. With the blinking again and again, the components of the eyeliner may enter the tear film and continue to act on the eye surface. Therefore, the investigators suspect that the use of eyeliner may be an important factor leading to dry eye disease. In order to explore the relationship between the use of eyeliner and dry eye disease, the investigators plan to collect eye surface characteristic data of the two groups of people who use eyeliner and who do not use it.Then use Raman analysis to explore whether the use of eyeliner will lead to changes in tear composition.The investigators intend to analyze the difference of tear composition between the two groups to understand the relationship between the change of tear composition and tear film stability.So that the investigators can identify the risk factors of dry eye disease, and provide basis for prevention and early treatment.